Insecticides (India) Limited has informed the Exchange regarding Outcome of Board Meeting held on May 28, 2026.
INSECTICID · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Insecticides (India) Limited reported audited FY2025-26 standalone revenue of Rs 1,44,963.24 lakh, down from Rs 1,99,994.96 lakh in FY2024-25, representing approximately 28% revenue decline. Standalone net profit for the year was Rs 11,303.74 lakh versus Rs 13,970.50 lakh in the prior year, a decline of about 19%. The Board approved formulation of Employee Stock Purchase Scheme 2026 with up to 2,00,000 equity shares (subject to shareholder approval at the 29th AGM on August 12, 2026). Mrs. Nikunj Aggarwal resigned as Whole Time Director, and Mr. Sanskar Aggarwal was appointed as Whole Time Director (Additional) for five years. M/s T Jain & Associates was appointed as Internal Auditor for five years. Both joint statutory auditors issued unmodified (clean) opinions on the financial results.
The significant revenue and profit decline of 28% and 19% respectively may concern investors, though the clean audit opinion provides comfort on financial reporting integrity. The leadership transition and new ESPS scheme indicate management continuity planning, but dilution from ESPS will need monitoring.